Basel, 21 September 2015
Reminder: Invitation to Roche Analyst Event at ECC 2015
We are pleased to invite you to an analyst briefing to discuss data presented on the Roche Group’s oncology products and pipeline at the European Cancer Congress 2015 in Vienna.
Ballroom 1, 2 & 3
Monday, 28 September 2015
5:00pm Registration desk opens
5:30pm Start of meeting
6:30pm End of meeting followed by a buffet reception
Download to my calendar (download to your calendar will be in local time Vienna)
- Understanding the immunobiology of combinations and role of predictive biomarkers
Ira Mellman, Ph.D., Vice President, Cancer Immunology, gRED Genentech
- ECC 2015 Roche cancer immunotherapy highlights:
- Atezolizumab phase II bladder and lung cancer data
Daniel S. Chen, M.D., Ph.D., Cancer Immunotherapy Franchise Head Product Development, Genentech/Roche
- Atezolizumab regulatory update and further development program
Cathi Ahearn, Lifecycle Leader atezolizumab lung and GU Cancers, Genentech/Roche
To register for the event, please follow the link
This presentation can also be accessed through a live audio webcast: http://ir.roche.com.
Alternatively you may dial in to the conference 10-15 minutes prior to the scheduled start, using the following dial-in numbers (listen-only mode, no live-access to speakers):
+41 (0)58 310 50 00 (Europe and ROW) or
+44 (0)203 059 58 62 (UK) or
+1 (1)631 570 5613 (USA)
To expedite the registration process on the day of the conference call, you may pre-register for the event. click here
The presentation slides will be available from the IR website at http://ir.roche.com.
A replay will be available following the event, for 48 hours. Access is by dialing:
+41 (0) 91 612 4330 (Europe and ROW) or
+44 (0) 207 108 6233 (UK) or
+1 (1) 631 982 4566 (USA)
Please enter the conference ID 10345 followed by the # sign.
A replay of the webcast will be available on demand on the Roche website. click here.